Showing results (61-70 of 178) with videos related to

Sort By:
Pageof 18
Annals of Surgery|July 1, 1985
Whole-body protein breakdown and 3-methylhistidine excretion during brief fasting, starvation, and intravenous repletion in manS F Lowry, G D Horowitz, M Jeevanandam, et al.
American Journal of Respiratory and Critical Care Medicine|February 1, 1997
Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in miceT van der Poll, C V Keogh, W A Buurman, et al.
The Journal of Infectious Diseases|December 1, 1996
Changes in endotoxin-induced cytokine production by whole blood after in vivo exposure of normal humans to endotoxinT van der Poll, S M Coyle, L L Moldawer, et al.
Biochemical and Biophysical Research Communications|October 16, 1989
The effect of interleukin-1 alpha and tumor necrosis factor alpha on the secretion of human chorionic gonadotropin by JAR human choriocarcinoma cellsM L Silen, A Firpo, T Francus, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|May 1, 1988
Effect of total parenteral nutrition on whole body protein kinetics in cachectic patients with benign or malignant diseaseM Jeevanandam, A Legaspi, S F Lowry, et al.
Annals of Surgery|August 1, 1981
Protean manifestations of neonatal hyperinsulinismT Mayer, M E Matlak, S F Lowry, et al.
Journal of the National Cancer Institute|April 1, 1981
Glucose disposal and gluconeogenesis from alanine in tumor-bearing Fischer 344 ratsS F Lowry, D M Foster, J A Norton, et al.
The Journal of Infectious Diseases|November 1, 1996
Interleukin-10 impairs host defense in murine pneumococcal pneumoniaT van der Poll, A Marchant, C V Keogh, et al.
The American Journal of Clinical Nutrition|August 1, 1987
Thermogenic and nitrogen response to submaximal exercise in parenterally repleted normal manS F Lowry, A Legaspi, J D Albert, et al.
The Journal of Infectious Diseases|January 1, 1997
Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13T van der Poll, R de Waal Malefyt, S M Coyle, et al.
Pageof 18